News: $IBRX (+0,49%) US FDA approves bladder cancer therapy from ImmunityBio!
Very positive for the rest of the pipeline ... lets go!
News: $IBRX (+0,49%) US FDA approves bladder cancer therapy from ImmunityBio!
Very positive for the rest of the pipeline ... lets go!